Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates

News News

Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
TrafficWeatherSports
  • 📰 KSLcom
  • ⏱ Reading Time:
  • 26 sec. here
  • 14 min. at publisher
  • 📊 Quality Score:
  • News: 56%
  • Publisher: 51%

Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD,

<p>WASHINGTON — Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for post-traumatic stress disorder, handing a potentially major set

</p><p>&quot&#x3B;It seems like there are so many problems with the data — each one alone might be OK, but when you pile them on top of each other … there's&am

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

KSLcom /  🏆 549. in US

Traffic Weather Sports Classifieds Cars Jobs Homes Television Radio Salt Lake Utah Local

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA panel votes against MDMA for PTSD, setting up hurdle to approvalFDA panel votes against MDMA for PTSD, setting up hurdle to approvalFDA advisers cited a variety of concerns with the trials submitted by Lykos Therapeutics as part of the application.
Read more »

Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocatesPanel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocatesThe panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of MDMA when used to treat post-traumatic stress disorder
Read more »

Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationPsychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationFederal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD
Read more »

MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationMDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationBy Matthew Perrone | Associated Press WASHINGTON — Federal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD — part of a decade…
Read more »

Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationPsychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationFederal health advisers are considering the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. Advisers to the Food and Drug Administration are scheduled to vote on the drug's safety and effectiveness Tuesday afternoon. It potentially sets the stage for federal approval later this year.
Read more »

Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationPsychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationFederal health advisers are considering the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Read more »



Render Time: 2025-04-14 03:29:42